SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,933.75 -301.71
( -0.39%)

Global Indices

Nasdaq

53,360.44 -120.34
(-0.23%)

Dow Jones

7,713.14 -52.92
(-0.68%)

Hang Seng

67,388.40 -1,831.85
(-2.65%)

Nikkei 225

10,735.70 15.40
(0.14%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9559391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

148.49

98533.48

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.68

Date	Headline
11-Aug-2026	Sensex, Nifty drops amid weak global cues; European mrkt decline
01-Aug-2026	Dr Reddys receives USFDA approval for rituximab biosimilar
23-Jul-2026	Dr Reddys Labs slides after Q1 PAT plunges 69% YoY to Rs 444 crore
22-Jul-2026	Dr Reddy's appoints Dr. Sridevi Khambhampaty as Global Head of Biologics
22-Jul-2026	Dr Reddy's Laboratories consolidated net profit declines 68.67% in the June 2026 quarter
22-Jul-2026	Dr Reddy's Labs Q1 PAT plunges 69% YoY to Rs 444 crore
10-Jul-2026	Dr Reddys Laboratories Ltd slips for fifth straight session
09-Jul-2026	Nifty trades above 24,000 level; European mrkt advance
09-Jul-2026	Market trade higher; consumer durables shares climb
09-Jul-2026	Dr Reddy’s Lab drops after quality issue delays semaglutide supplies

<< < 1 2 3 ... > >>

76,933.75 -301.71 ( -0.39%)

53,360.44 -120.34 (-0.23%)

7,713.14 -52.92 (-0.68%)

67,388.40 -1,831.85 (-2.65%)

10,735.70 15.40 (0.14%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)